OCGN - CLF CHWY OCGN and LCTX among premarket gainers

Arcadia Biosciences RKDA +37% on Q4 results.ProPhase Labs PRPH +31% on VaccTrack acquisition.ClearOne CLRO +19% on Q4 results.Taoping TAOP +17% on share purchase agreement with Genie Global Limited.SPAR Group SGRP +16% on Q4 results.Greenlane Holdings GNLN +15% on acquiring Kushco.Ocugen (OCGN) +14%.Surface Oncology SURF +13% as its SRF617 gets FDA orphan drug status.Broadwind (BWEN) +13%.Chewy CHWY +12% on Q4 results.Delcath Systems DCTH +14% on positive Hepzato data in metastatic ocular melanoma.X Financial (XYF) +9%.AzurRx BioPharma (AZRX) +10%.Lineage Cell Therapeutics (LCTX) +9%.Windtree Therapeutics (WINT) +8%.CASI Pharmaceuticals (CASI) +8%.FreightCar America (RAIL) +8%.China HGS Real Estate Inc. (HGSH) +8%.Ocean Power Technologies (OPTT) +7%.Astrotech Corporation (ASTC) +7%.Pyxis Tankers (PXS) +7%.Cleveland-Cliffs CLF +6% on financial guidance.Savara (SVRA) +6%.CTI BioPharma CTIC +6% on rolling NDA submission of pacritinib.U.S. Concrete (USCR) +6%.

For further details see:

CLF, CHWY, OCGN and LCTX among premarket gainers